Journal of pain and symptom management
-
J Pain Symptom Manage · Jul 2013
Long-term control of refractory hemorrhagic radiation proctitis with ozone therapy.
Persistent or severe hemorrhagic radiation proctitis (HRP) has limited therapeutic options. ⋯ Persistent advanced HRP was significantly improved with O3T. The addition of O3T can be useful as a complementary treatment in the long-term management of HRP and, as such, merits further evaluation.
-
J Pain Symptom Manage · Jul 2013
Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22).
The Functional Assessment of Cancer Therapy-Head and Neck is a well-validated assessment of quality of life used with patients diagnosed with head and neck cancers (HCNs). The present study is an attempt to evaluate and modify this instrument as necessary in light of the recent regulatory guidelines from the Food and Drug Administration on the use of patient-reported outcomes in clinical trials. ⋯ The National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Head and Neck Cancer Symptom Index-22 adequately reflects symptom and side effect concerns of advanced HCN patients as well as oncology physicians. This instrument can be used to evaluate the most important disease-related symptoms, treatment side effects, and function/well-being in patients with advanced HCNs in clinical practice and research.
-
J Pain Symptom Manage · Jul 2013
Use of opioid analgesics among older persons with colorectal cancer in two health districts with palliative care programs.
Prescription of opioid analgesics is a key component of pain management among persons with cancer at the end of life. ⋯ PCPs may play an important role in enabling access to end-of-life care within the community.
-
The HIV/AIDS epidemic in boys and men with hemophilia began in the early 1980s with the puzzling occurrence of systemic illness and fatal opportunistic infections in patients who had received plasma-derived clotting factor concentrates. This brief narrative describes one physician's experience in caring for patients with hemophilia and HIV infection early in the epidemic.